$119.3 M

EYES Mkt cap, 14-Jun-2018

$976 K

Second Sight Medical Products Revenue Q1, 2018
Second Sight Medical Products Gross profit (Q1, 2018)308 K
Second Sight Medical Products Gross profit margin (Q1, 2018), %31.6%
Second Sight Medical Products Net income (Q1, 2018)-9.8 M
Second Sight Medical Products EBIT (Q1, 2018)-9.8 M
Second Sight Medical Products Cash, 31-Mar-20185 M

Second Sight Medical Products Financials

Second Sight Medical Products Income Statement

Annual

USDFY, 2015FY, 2016FY, 2017

Revenue

9 m4 m8 m

Revenue growth, %

(55%)

Cost of goods sold

5.3 m10.1 m5.1 m

Gross profit

3.7 m(6.1 m)2.8 m

Gross profit Margin, %

41%(153%)36%

Sales and marketing expense

9.6 m

General and administrative expense

8.2 m10.1 m10.9 m

Operating expense total

8.2 m10.1 m31.5 m

EBIT

(20 m)(33.2 m)(28.6 m)

EBIT margin, %

(224%)(833%)(359%)

Interest income

2 k31 k93 k

Net Income

(20 m)(33.2 m)(28.5 m)

Quarterly

USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018

Revenue

1.7 m2.7 m2.2 m1.1 k1 m1.2 m1 m2.2 m1.6 m976 k

Cost of goods sold

1.3 m1.6 m757.1 k912 3.2 m2.6 m1.1 m1.1 m1 m668 k

Gross profit

404.3 k1.1 m1.5 m141 (2.2 m)(1.4 m)(118 k)1.1 m609 k308 k

Gross profit Margin, %

24%41%66%13%(213%)(122%)(12%)50%38%32%

Sales and marketing expense

3 m

General and administrative expense

1.7 m2 m2.4 m2.4 k2.6 m2.6 m2.7 m2.9 m3.2 m

Operating expense total

5.4 m6 m6.1 m6 k6.3 m7.1 m7.4 m8 m7.4 m10.1 m

EBIT

(5 m)(4.9 m)(4.7 m)(5.8 k)(8.5 m)(8.5 m)(7.6 m)(6.9 m)(6.7 m)(9.8 m)

EBIT margin, %

(292%)(186%)(209%)(553%)(820%)(720%)(749%)(307%)(419%)(1001%)

Interest income

796 352 84 5 3 k11 k7 k29 k33 k16 k

Net Income

(5 m)(4.9 m)(4.7 m)(5.8 k)(8.5 m)(8.5 m)(7.5 m)(6.8 m)(6.7 m)(9.8 m)

Second Sight Medical Products Balance Sheet

Annual

USDFY, 2015FY, 2016FY, 2017

Cash

239 k539 k604 k

Accounts Receivable

1.5 m274 k1.8 m

Inventories

1.1 m717 k2.7 m

Current Assets

26.8 m15.3 m13.2 m

PP&E

1.4 m1.5 m1.3 m

Total Assets

28.2 m16.8 m14.5 m

Accounts Payable

710 k1.2 m752 k

Current Liabilities

8 m5.7 m6.6 m

Additional Paid-in Capital

27.3 m30.7 m40.5 m

Retained Earnings

(172.7 m)(205.9 m)(234.4 m)

Total Equity

20.3 m11.1 m7.9 m

Financial Leverage

1.4 x1.5 x1.8 x

Quarterly

USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018

Cash

652.3 k407.4 k268.7 k459 184 k277 k266 k763 k639 k5 m

Accounts Receivable

1.3 m1.2 m1.3 m822 677 k447 k782 k926 k668 k475 k

Inventories

6.4 m6.8 m8.1 m9.1 k7.4 m5.8 m3.1 m3.1 m462 k2.8 m

Current Assets

38.4 m35.7 m31.9 m21.1 k32.5 m24.7 m28.6 m22.8 m17.7 m9.1 m

PP&E

1 m1.1 m1.4 m1.4 k1.5 m1.5 m1.5 m1.4 m1.3 m

Total Assets

39.5 m36.9 m33.3 m22.6 k34.1 m26.3 m30.1 m24.3 m19.1 m10.4 m

Accounts Payable

414.4 k330.4 k544.4 k707 671 k694 k895 k558 k826 k1.6 m

Current Liabilities

9 m8.8 m8.8 m6.6 k6 m5.7 m5.8 m5.5 m6.1 m6.9 m

Additional Paid-in Capital

25.1 m25.7 m26.5 m28.3 k29 m29.9 m37.7 m38.7 m39.6 m41.8 m

Retained Earnings

(157.6 m)(162.5 m)(167.2 m)(178.5 k)(187 m)(195.5 m)(213.4 m)(220.3 m)(227 m)(244.1 m)

Total Equity

30.5 m28.1 m24.5 m15.9 k28.1 m20.6 m24.4 m18.8 m13 m3.5 m

Financial Leverage

1.3 x1.3 x1.4 x1.4 x1.2 x1.3 x1.2 x1.3 x1.5 x2.9 x

Second Sight Medical Products Cash Flow

Annual

USDFY, 2015FY, 2016FY, 2017

Net Income

(20 m)(33.2 m)(28.5 m)

Depreciation and Amortization

335 k432 k

Accounts Receivable

(793 k)955 k(1.4 m)

Inventories

(2.5 m)10 k3.9 m

Accounts Payable

197 k446 k(419 k)

Cash From Operating Activities

(20.5 m)(25.1 m)(23.9 m)

Purchases of PP&E

(762 k)(490 k)(265 k)

Cash From Investing Activities

17.5 m4.9 m2.8 m

Cash From Financing Activities

2.8 m20.5 m21.2 m

Quarterly

USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018

Net Income

(5 m)(4.9 m)(4.7 m)(5.8 k)(8.5 m)(8.5 m)(7.5 m)(14.4 m)(6.7 m)(9.8 m)

Depreciation and Amortization

111 k

Accounts Receivable

1.3 m1.2 m1.3 m822 677 k447 k(454 k)(704 k)668 k1.4 m

Inventories

1 m1.9 m462 k21 k

Accounts Payable

414.4 k330.4 k544.4 k707 671 k694 k(269 k)(528 k)826 k857 k

Cash From Operating Activities

(6.6 m)(12.6 m)(6.8 m)

Purchases of PP&E

(89 k)(151 k)(68 k)

Cash From Investing Activities

(7.2 m)(68 k)

Cash From Financing Activities

19.7 m19.9 m4 m

Second Sight Medical Products Ratios

USDY, 2018

Financial Leverage

2.9 x
Report incorrect company information

Second Sight Medical Products Operating Metrics

FY, 2016

Patents Issued

381

Patents Pending

126
Report incorrect company information